Successful Treatment of Refractory Electrical Storm With Landiolol After More Than 100 Electrical Defibrillations

Kenta Kanamori; Takashi Aoyagi; Takashi Mikamo; Kenta Tsutsui; Tomoyuki Kunishima; Hideko Inaba; Noriyuki Hayami; Yuji Murakawa

doi:10.1536/ihj.15-102

This article has now been updated. Please use the final version.

Successful Treatment of Refractory Electrical Storm With Landiolol After More Than 100 Electrical Defibrillations

Kenta Kanamori, Takashi Aoyagi, Takashi Mikamo, Kenta Tsutsui, Tomoyuki Kunishima, Hideko Inaba, Noriyuki Hayami, Yuji Murakawa

Author information

Kenta Kanamori
Department of Internal Medicine, Teikyo University School of Medicine University Hospital
Takashi Aoyagi
Department of Internal Medicine, Teikyo University School of Medicine University Hospital
Takashi Mikamo
Department of Internal Medicine, Teikyo University School of Medicine University Hospital
Kenta Tsutsui
Department of Internal Medicine, Teikyo University School of Medicine University Hospital
Tomoyuki Kunishima
Department of Internal Medicine, Teikyo University School of Medicine University Hospital
Hideko Inaba
Department of Internal Medicine, Teikyo University School of Medicine University Hospital
Noriyuki Hayami
Department of Internal Medicine, Teikyo University School of Medicine University Hospital
Yuji Murakawa
Department of Internal Medicine, Teikyo University School of Medicine University Hospital

Keywords: Ventricular tachycardia, Beta-blocker, Myocardial infarction, Transthoracic defibrillation

JOURNAL FREE ACCESS Advance online publication

Article ID: 15-102

DOI https://doi.org/10.1536/ihj.15-102

The final version of this article is now available: Vol. 56 (2015), No. 5 pp. 555-557

Details

Abstract

Electrical storm (ES) was observed in an 82-year-old man with recent myocardial infarction. Conventional therapy, including amiodarone, could not suppress the ES. After more than 100 electrical defibrillations, we were finally able to control the ES with the administration of landiolol. It is known that landiolol can inhibit ES. However, we hesitate to use landiolol in patients with low cardiac output. We would like to emphasize that careful use of landiolol should be considered in patients with refractory ES after myocardial infarction, although cardiac output is severely reduced.

Corresponding author

Register with J-STAGE for free!